FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Delayed Börse Stuttgart 15:53:29 23/05/2024 BST | ||
| 9.95 EUR | +15.43% |
|
| Current month | -15.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 9.95 | +15.43% |
| 22/05/24 | 8.62 | -2.27% |
| 21/05/24 | 8.82 | +10.53% |
| 20/05/24 | 7.98 | -3.74% |
| 17/05/24 | 8.29 | -0.48% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 03:53 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2XMB |
| ISIN | DE000MG2XMB8 |
| Date issued | 24/04/2024 |
| Strike | 1,223 p |
| Maturity | Unlimited |
| Parity | 0.29 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.39 € |
|---|---|
| Lowest since issue | 7.94 € |
| Spread | 0.05 € |
| Spread % | 0.51% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.92
USD
Average target price
16.31
USD
Spread / Average Target
+26.28%
- Stock Market
- Certificates
- Certificat
